Human Adenovirus C Serotype 5 With E1 Gene Controlled By Chromogranin A Promoter And Hexon Modified With Protein Transduction Domain Motif

1 trials

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

1 Countries

Phase I

Phase I: 1

Indications tested

Neuroendocrine carcinoma metastatic 1

Sponsors using this IMP

Uppsala University 1

All trials

1 total

Treatment of neuroendocrine neoplasms with genetically modified adenovirus Ended

2024-517654-10-00 Phase I 1 country Uppsala University

Showing 1–1 of 1 trials

← All drugs A–Z